Last reviewed · How we verify
Negative control dentifrice
At a glance
| Generic name | Negative control dentifrice |
|---|---|
| Sponsor | Procter and Gamble |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation (NA)
- Diagnostic Accuracy of Cold, Heat, and Electric Pulp Tests
- Intra Oral Application (IOA) Testing Study of a Stannous Toothpaste (NA)
- Intraoral Appliance (IOA) Model Evaluating the Efficacy of a Whitening Toothpaste (NA)
- Intra Oral Appliance (IOA) Model Evaluating the Efficacy of Sensitive Toothpaste (NA)
- Evaluation of a Toothpaste Containing a Gum Health Active in Participants With Gingival Problem (NA)
- Clinical Study to Evaluate the Anti-cavity Efficacy of Three Dentifrices: An In Situ Model (PHASE3)
- A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Negative control dentifrice CI brief — competitive landscape report
- Negative control dentifrice updates RSS · CI watch RSS
- Procter and Gamble portfolio CI